CPChristian Prinz

Christian Prinz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christian Prinz has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rethinking cardiac resynchronization therapy: The impact of ventricular dyssynchrony on outcome

    by Christian Prinz, Cinthia Duarte Felice, Roman Lehmann, Maria Schwarz, Eva-Maria Prinz, Thomas Bitter, Jürgen Vogt, Barbara Lamp, Lothar Faber, Dieter Horstkotte


  • Left Ventricular Dyssynchrony Predicts Clinical Response to CRT – A Long‐Term Follow‐Up Single‐Center Prospective Observational Cohort Study

    by Christian Prinz, Roman Lehmann, Maria Schwarz, Eva‐Maria Prinz, Thomas Bitter, Jürgen Vogt, Frank van Buuren, Nikola Bogunovic, Barbara Lamp, Dieter Horstkotte, et al.

    Background Until now, there is no consensus regarding the definition of a clinical response to cardiac resynchronization therapy (CRT) in patients with chronic heart failure (CHF) and systolic left ventricular (LV) dysfunction. The aim of this study was to evaluate if echocardiography is predictive for an objective improvement in exercise capacity during long‐term follow‐up of CRT. Methods Each patient underwent echocardiography and spiroergometry both at baseline and at last follow‐up. Left ventricular dyssynchrony (LVD) before CRT was defined by tissue Doppler imaging (TDI) as intra‐LV delay ≥40 msec (septal‐lateral or anterior‐posterior). Clinical response to CRT was defined as increase of peakVO2 or as increase of maximal workload >10% as compared to baseline. Results Mean follow‐up was 69 ± 37 months. From the 238 consecutive patients included in the study, 141 (59%) were classified as clinical responders and 97 (41%) as nonresponders. Baseline data of responders and nonresponders were comparable. However, clinical responders showed more often LVD (64%) than nonresponders (42%, P = 0.004). On multivariate regression analysis, nonischemic origin of CHF (β‐coefficient in the final model 0.1, P = 0.04) and LVD at baseline (β‐coefficient in the final model 0.2, P < 0.001) were independently associated with clinical response during long‐term follow‐up. Patients with LVD at baseline had significant more often an improvement of left ventricular ejection fraction >10% (P = 0.02) and a reduction of left ventricular end‐diastolic diameter (LVEDD) >10% (P < 0.01) than patients without LVD at baseline. Conclusions LVD at baseline as assessed by a straightforward echocardiographic approach predicts the long‐term clinical response to CRT and is associated with a more pronounced reverse LV remodeling.


  • Myocardial Fibrosis Severity on Cardiac Magnetic Resonance Imaging Predicts Sustained Arrhythmic Events in Hypertrophic Cardiomyopathy

    by Christian Prinz, Maria Schwarz, Ivan Ilic, Kai Thorsten Laser, Roman Lehmann, Eva-Maria Prinz, Thomas Bitter, Jürgen Vogt, Frank van Buuren, Nikola Bogunovic, et al.


  • Open Access

    Echocardiographic particle image velocimetry in a patient with severe diastolic dysfunction

    by Christian Prinz, Barbara Jurczak, Lothar Faber, Dieter Horstkotte

    Particle image velocimetry (PIV echocardiography; software: Hyper Flow®, version 6.0.2.0), applied to contrast-enhanced echocardiographic images, is a new technique to display and quantify blood flow velocity and direction and allows new insights into typical cardiac blood flow patterns, such as vortices. A vortex is a mass of fluid with a circular motion containing kinetic energy.


  • The importance of training in echocardiography

    by Christian Prinz, Jelena Dohrmann, Frank van Buuren, Thomas Bitter, Nikola Bogunovic, Dieter Horstkotte, Lothar Faber

    To investigate the training effect in echocardiography by using recent hand-held ultrasound scanners (HANDs). In this prospective study, 320 consecutive patients were scanned with HAND by an inexperienced ultrasonographer over a period of 8 weeks. Imaging studies were compared with high-end echocardiography as gold standard. Segmental endocardial border delineation was scored to describe image quality. Assessment of left ventricular dimensions, regional/global left ventricular function and grading of valve disease were compared. A significant reduction in examination duration, improvement in image quality, substantial agreement in functional assessment (κ > 0.61, P < 0.01) and wall motion scoring (κ=0.67, P < 0.01) could be observed over time. The correlation in left ventricular measurements was excellent (r > 0.98, P < 0.01). The detection of valve diseases and pericardial effusions was sufficient, but the grading only moderate (κ < 0.6). Well-grounded training in echocardiography leads to a rapid improvement in image acquisition and interpretation over a period of a few weeks. Basic diagnostic findings could be interpreted with high accuracy after short training. Interpretation of complex findings remained difficult. The time needed to carry out an examination using pocket echocardiography could not be reduced to less than 3-4 min per patient. New educational concepts are warranted.


  • Open Access

    Can echocardiographic particle image velocimetry correctly detect motion patterns as they occur in blood inside heart chambers? A validation study using moving phantoms

    by Christian Prinz, Reka Faludi, Andrew Walker, Mihaela Amzulescu, Hang Gao, Tokuhisa Uejima, Alan G Fraser, Jens-Uwe Voigt

    Aims: To validate Echo Particle Image Velocimetry (PIV) Methods: High fidelity string and rotating phantoms moving with different speed patterns were imaged with different high-end ultrasound systems at varying insonation angles and frame rates. Images were analyzed for velocity and direction and for complex motion patterns of blood flow with dedicated software. Post-processing was done with MATLAB-based tools (Dflow, JUV, University Leuven). Results: Velocity estimation was accurate up to a velocity of 42 cm/s (r = 0.99, p < 0.001, mean difference 0.4 ± 2 cm/s). Maximally detectable velocity, however, was strongly dependent on frame rate and insonation angle and reached 42 cm/s under optimal conditions. At higher velocities estimates became random. Direction estimates did depend less on velocity and were accurate in 80-90%. In-plane motion patterns were correctly identified with three ultrasound systems. Conclusion: Echo-PIV appears feasible. Velocity estimates are accurate, but the maximal detectable velocity depends strongly on acquisition parameters. Direction estimation works sufficiently, even at higher velocities. Echo-PIV appears to be a promising technical approach to investigate flow patterns by echocardiography.


  • In patients with hypertrophic cardiomyopathy myocardial fi brosis is associated with both left ventricular and left atrial dysfunction

    by Christian Prinz, Frank Vanbuuren, Nicola Bogunovic, Thomas Bitter, Lothar Faber, Dieter Horstkotte

    The aim of this study was to assess LA function by two-dimensional speckle-tracking echocardiography and its relation with myocardial fibrosis in hypertrophic cardiomyopathy (HCM). We enrolled 30 consecutive HCM-patients in our study (20 males; age: 49.7 +/- 10.4 years, NYHA-class: 1.9 +/- 0.7). Echocardiography was performed with assessment of global longitudinal LV strain (epsilon) and LA epsilon and strain-rate parameters (systolic, early diastolic, and late diastolic during atrial contraction). Each patient received delayed-enhancement magnetic resonance imaging (DE-MRI) to check for myocardial fibrosis. We divided the patients into two groups. Patients of group 1 had no fibrosis, group 2 demonstrated moderate or severe fibrosis in > or = 2 segments using a 17 segment-model of the LV. Moderate and severe fibrosis was observed in 20 patients (group 2: 66.7%). Global longitudinal LV epsilon (-13.0 +/- 2.4 vs -20.6 +/- 3.2%, P < 0.001) and peak LA epsilon (-0.2 +/- 3.9 vs 17.9 +/- 6.7%, P < 0.001) were reduced in group 2 in comparison with patients without myocardial fibrosis. In all patients peak LA epsilon correlated with global longitudinal LV epsilon (r = -0.78, P < 0.001). Patients with considerable myocardial fibrosis (group 2) had a higher indexed left atrial volume (35.7 +/- 12.8 ml/m2 vs 24.1 +/- 8.6 ml/m2, P = 0.016). New York Heart Association class (NYHA) was higher in patients with severe myocardial fibrosis (2.2 +/- 0.7 vs 1.3 +/- 0.5) and correlated with peak LA (r = -0.5, P = 0.008) and global LV epsilon (r = 0.5, P = 0.005). Occurrence of myocardial fibrosis in hypertrophic cardiomyopathy is associated with left atrial and ventricular dysfunction as well as with the severity of heart failure symptoms.


  • Myocardial Fibrosis Is Associated with Biventricular Dysfunction in Patients with Hypertrophic Cardiomyopathy

    by Christian Prinz, Frank van Buuren, Lothar Faber, Thomas Bitter, Nikola Bogunovic, Wolfgang Burchert, Dieter Horstkotte

    To assess left (LV) and right ventricular (RV) function by two-dimensional (2D) speckle tracking echocardiography and its relation to myocardial fibrosis in hypertrophic cardiomyopathy (HCM). We enrolled 50 HCM patients (30 male; 47.3 ± 9.9 years) in our study. Each patient received echocardiography with modern high-end scanners. For speckle tracking analysis of LV and RV function the dedicated software was used. The presence of myocardial fibrosis was detected by cardiac magnetic resonance imaging (MRI). For intraobserver variability of RV global longitudinal strain, we found a correlation of r = 0.89 (p < 0.001) with a minor bias of 4.9 ± 2.9%. On cardiac MRI 30 patients (60%) demonstrated late gadolinium-enhancement (LGE) of the LV. Of these patients only 7% showed LGE of the RV. HCM patients with myocardial fibrosis had less global longitudinal LV strain in comparison to patients without myocardial fibrosis (-12.8 ± 2.2 vs -21.1 ± 2.6, P < 0.001), thicker interventricular septums (23.7 ± 4.0 vs 19.2 ± 5.1, P < 0.001), larger left atria (34.9 ± 7.1 vs 23.9 ± 5.1, P < 0.001), and impaired diastolic function (E/A-ratio: 1.02 ± 0.22 vs 1.15 ± 0.18, P < 0.01). Comparable results were found for RV function. LV and RV strain correlated with r = 0.85 (p < 0.001). HCM is not only a disease of the LV. LGE in HCM is associated with both LV and RV dysfunction. Although RV LGE occurs only in a minority of patients with HCM and LV fibrosis, speckle tracking echocardiography is feasible for evaluating LV and RV dysfunction in these patients.


  • Sleep apnoea in severe aortic stenosis

    by Christian Prinz, Thomas Bitter, Olaf Oldenburg, Lothar Faber, Dieter Horstkotte, Cornelia Piper

    Background There are as yet no data on the prevalence of sleep apnoea in patients with severe aortic stenosis (AS). Aims To assess the occurrence, severity and clinical correlates of sleep apnoea in patients with AS. Methods During a 4-month period in 2010, 67 patients were consecutively included in this study, 42 of which (19 men; mean±SD age 72±9 years) had severe AS (aortic valve opening area ≤1.0 cm2); all were investigated with cardiorespiratory polygraphy. Sleep apnoea was diagnosed if the apnoea–hypopnoea index (AHI) (median (lower quartile, upper quartile)) was ≥5/h. The control group of 25 patients matched for age, body mass index and sex had angiographic exclusion of coronary artery disease, regular left ventricular ejection fraction, and no valve disease. Results Sleep apnoea was found in 30/42 patients with AS (71%; AHI=23/h (14/h, 36/h)). The severity was significantly greater in patients with severe AS than in the control group (AHI=12/h (8/h, 17/h)) (p2=0.3). The severity of CSA correlated with pulmonary artery pressure (r=0.7, p2 than those with OSA and those without sleep apnoea (pConclusions Sleep apnoea is common in patients with severe AS. The severity of CSA correlates with pulmonary hypertension, which may suggest that myocardial adaptation is exhausting.


  • Incidence of Sleep-Disordered Breathing in Patients With Hypertrophic Cardiomyopathy

    by Christian Prinz, Thomas Bitter, Olaf Oldenburg, Dieter Horstkotte, Lothar Faber

    The authors investigated the prevalence of sleep-disordered breathing (SDB) together with its clinical correlations in patients with hypertrophic cardiomyopathy (HCM). A total of 113 consecutive patients including 63 patients with HCM (40 men; mean age, 59.5±13.0 years; New York Heart Association class, 2.0±0.9) underwent cardiorespiratory polygraphy in addition to their clinical work-up including echocardiography. Patients with an apnea-hypopnea-index (AHI) ≥5/h were considered to have SDB. If thoracic and abdominal inspiration efforts were documented, SDB was considered to be obstructive sleep apnea (OSA), otherwise SDB was considered to be central sleep apnea (CSA). The age- and sex-matched control group of 50 patients had exclusion of coronary artery disease by angiography, and normal left ventricular (ejection fraction ≥55%) and valvular function. SDB was diagnosed in 52 patients (82.5% vs 72% in the control group; P =not significant) with a mean AHI of 23.0±17.8/h. Severity of SDB was higher in patients with HCM than in the control group (AHI 12.2±7.6/h; P =.003). OSA was documented in 39 patients (AHI 21.2±16.5/h) and CSA in 13 (AHI 28.4±20.9/h). The severity of SDB correlated with New York Heart Association functional class (η=0.9, η(2) =0.811) and with left ventricular end-diastolic (r=0.6, P <.01) and left atrial (r=0.4, P <.01) diameter. No correlations were found between SDB and other clinical or echocardiographic parameters. SDB is common in patients with hypertrophic cardiomyopathy, with a predominance of OSA and correlations with markers of left ventricular function.